[Value of radiotherapy in metastases of hypernephroid carcinoma].
52 own cases are retrospectively evaluated in order to investigate the importance of radiotherapy for the treatment of the metastasizing hypernephroma. The treatment is above all indicated in case of painful osseous metastases, but the success is retarded and often appears only after a focal dose of more than 30 Gy. Furthermore, radiotherapy of brain metastases and lymph node metastases within the mediastinum is often successful, whereas the irradiation of pulmonary metastases has to be judged less favorably. In most of all cases, surgical interventions are not an alternative, but a complementary treatment to radiotherapy. In default of promising systemic therapy methods, radiotherapy of metastases of the hypernephroma are a possibility to achieve a real palliative effect.
D000230:Adenocarcinoma / Q000532:radiotherapy* / Q000556:secondary; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000556:secondary; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D008207:Lymphatic Metastasis; D008479:Mediastinal Neoplasms / Q000532:radiotherapy / Q000556:secondary; D011867:Radioisotope Teletherapy; D012189:Retrospective Studies
D003037:Cobalt Radioisotopes
Wertigkeit der Strahlentherapie bei Metastasen des hypernephroiden Karzinoms.